{"id":38396,"date":"2018-09-27T18:02:51","date_gmt":"2018-09-27T16:02:51","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=38396"},"modified":"2018-09-27T19:08:24","modified_gmt":"2018-09-27T17:08:24","slug":"top-10-delle-multinazionali-farmaceutiche-nel-2018","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/top-10-delle-multinazionali-farmaceutiche-nel-2018\/","title":{"rendered":"Pharmaceutical multinationals, the Top 10 in 2018"},"content":{"rendered":"

The ranking of the top 10 pharmaceutical multinationals in 2018, considering not only turnover but also parameters such as investments and growth.<\/em><\/p>\n

Top 10 Pharmaceutical Companies 2018<\/a><\/p>\n

There pharmaceutical<\/strong> it's a business<\/em> gigantic global size. In 2017 alone, the world's top ten pharmaceutical companies generated revenues of $437.26 billion (about 40% of global market share). A figure well above the GDP<\/em> of most countries in the world.<\/p>\n

The entire world pharmaceutical market is estimated at more than 1,000 billion dollars and is estimated to reach 1,400 \"\"<\/a>billions by 2020. TheEurope<\/em> western, alone, represents the 20% of this market, while the North America<\/em>\u00a0the 37% (2017).<\/p>\n

The leader is F. Hoffmann-La Roche<\/h2>\n

Given these numbers, it's easy to figure it all out the importance of pharmaceutical multinationals<\/strong> in the world economy. That is why the analysis prepared by IgeaHub\u00a0<\/em>of the ten most important companies, has aroused great interest among industry experts.<\/p>\n

They have been taken into consideration 7 criteria<\/strong>, including revenue levels and growth, R&D investments, income per employee, and the percentage of revenue generated by the top 3 products. So, weighing all these parameters, the ranking of the 10 most important pharmaceutical multinationals<\/strong> in 2018.<\/p>\n

Leader<\/em> of the ranking is the\u00a0F. Hoffmann-La Roche<\/strong>, which manufactures and sells drugs for\u00a0oncology, diabetes, ophthalmology, neuroscience, immunology and infectious diseases. Furthermore, in 2017, the three best-selling drugs of the Swiss multinational were\u00a0MabThera\/Rituxan<\/em>, Herceptin<\/em> And Perjeta<\/em>.<\/span><\/span><\/p>\n

In second place we find the US Pfizer<\/strong>\u00a0which, at nearly $53 billion, beats all others in terms of absolute revenue.<\/p>\n

But here is the complete ranking, dominated by US (6), Swiss (2), British (1) and French (1) companies. The turnover is that of 2017 and refers only to the pharmaceutical branch of the company to which it refers.<\/p>\n

\"\"<\/a><\/p>\n

\"\"<\/a><\/p>\n

\"\"<\/a><\/p>\n

Related news: Top 10 Pharmaceutical Companies 2018<\/a><\/p>\n

Video <\/a><\/p>\n

F. Hoffmann-La Roche Ltd (Switzerland)<\/span><\/p>\n

Hoffmann-La Roche (Roche) is a research-focused healthcare company that develops, manufactures and delivers innovative therapeutics and diagnostic instruments and tests. Roche offers medicine in oncology, diabetes, ophthalmology, neuroscience, immunology, and infectious diseases. In 2017, top 3 best-selling drugs include cancer treatments MabThera\/Rituxan, Herceptin, and Perjeta.<\/span><\/p>\n

Pfizer (US)<\/span><\/p>\n

Pfizer is a research-based pharmaceutical company engaged in the wellness, prevention and treatment for diseases across a broad range of therapeutic areas. The company operates through Innovative Health and Established Health business segments. Pfizer offers medicine in cardiology, oncology, and immunology. In 2017, top 3 best-selling drugs include Lyrica, Prevnar 13\/Prevenar 13, and Ibrance.<\/span><\/p>\n

AbbVie (US)<\/span><\/p>\n

AbbVie, is a research-based biopharmaceutical company that develops and markets advanced therapies focused on treating rheumatology, gastroenterology, dermatology, oncology, virology, neurological disorders and other related metabolic and critical conditions. In 2017, top 3 best-selling drugs include Humira, Imbruvica, and HCV.<\/span><\/p>\n

Johnson & Johnson (US)<\/span><\/p>\n

Johnson & Johnson (J&J) is a pharmaceutical and consumer goods manufacturing company and its subsidiaries are engaged in the research, development, manufacturing and selling of pharmaceuticals, medical devices and consumer health products. Johnson & Johnson offers medicine in Hepatitis C, HIV\/AIDS, Arthritis, and digestive conditions. In 2017, top 3 best-selling drugs include Remicade, Stelara, and Invega Sustenna \/ Xeplion \/ Trinza \/ Trevicta.<\/span><\/p>\n

Sanofi (France)<\/span><\/p>\n

Sanofi is a French pharmaceutical company involved in research, development, manufacturing and marketing of therapeutic solutions. Sanofi offers medicines in prescription and over the counter (OTC) categories having major drugs in central nervous system, cardiovascular, oncology, diabetes, internal medicine, and vaccines. In 2017, top 3 best-selling drugs include Lantus, Lovenox, and Aubagio.<\/span><\/p>\n

Merck & Co. (US)<\/span><\/p>\n

Merck, research and development company, known as MSD outside the United States and Canada, offers health solutions through its prescription medicines, vaccines, biological therapies and animal health products. Merck offers medicines in oncology, fertility, neurodegenerative diseases, and endocrinology. In 2017, top 3 best-selling drugs include Januvia \/ Janumet, Keytruda, and Gardasil \/ Gardasil 9.<\/span><\/p>\n

Novartis (Switzerland)<\/span><\/p>\n

Novartis is a global healthcare company based in Basel, Switzerland. The company's portfolio includes innovative biological therapies and pharmaceuticals in several disease areas including oncology, cardiology, neurology, immunology, eye care, generic and bio-similar medicines. In 2017, top 3 best-selling drugs include Gilenya, Cosentyx, and Glivec.<\/span><\/p>\n

Gilead Sciences (US)<\/span><\/p>\n

Gilead is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. Gilead Sciences focused on virology, hepatology, hematology, oncology, cardiovascular, inflammation and respiratory diseases. In 2017, top 3 best-selling drugs include Harvoni, Epclusa, and Truvada.<\/span><\/p>\n

GlaxoSmithKline (UK)<\/span><\/p>\n

GlaxoSmithKline is research-focused pharmaceutical company engaged in discovering, manufacturing and distributing pharmaceutical products including prescription medicines, vaccines and consumer healthcare. It offers medicines in cardiovascular disease, gynecology, diabetes, anti-infective, dermatology, and respiratory diseases. In 2017, top 3 best-selling drugs include Seretide\/Advair, Triumeq, and Tivicay.<\/span><\/p>\n

Amgen (US)<\/span><\/p>\n

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California that discovers and develops innovative therapies in both biopharmaceuticals and small molecule drugs. In 2017, top 3 best-selling drugs include Enbrel, Neulasta, and Aranesp.<\/span><\/p>\n

Sources: SEC filings, companies websites, and annual reports.<\/em><\/p>\n

Related news: Galen Award 2018: Ocrevus, Spinraza, Alofisel and Januvia win<\/a><\/p>\n

Big Pharma's reputation improves: here are the top ten companies<\/a><\/p>\n

Pharma family matter, the top 10 of Italian capital groups<\/a><\/p>\n

Top Employers 2017: here are the certified pharmaceutical companies in Italy<\/a><\/p>\n

\u201cTop 10\u201d highest paid CEOs in the world, leading CEO of Regeneron<\/a><\/p>","protected":false},"excerpt":{"rendered":"

La classifica delle 10 migliori multinazionali farmaceutiche nel 2018, considerando non solo il fatturato ma anche parametri come investimenti e crescita. Top 10 Pharmaceutical Companies 2018 La farmaceutica \u00e8 un business globale di dimensioni gigantesche. Soltanto nel 2017, le dieci pi\u00f9 importanti aziende farmaceutiche del mondo hanno\u00a0generato un fatturato di 437,26 miliardi di dollari (circa …<\/p>","protected":false},"author":4,"featured_media":38398,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[47],"class_list":["post-38396","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-big-pharma"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/38396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=38396"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/38396\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/38398"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=38396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=38396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=38396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}